The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells
Cancer therapy is one of the most important challenges of modern medical and chemical sciences. Among the many methods of combating cancer, chemotherapy plays a special role. Imperfect modern chemotherapy justifies continuing the search for new, more effective, and safe drugs. Sulfonamides are the c...
Main Authors: | Agnieszka Gornowicz, Anna Szymanowska, Mariusz Mojzych, Robert Czarnomysy, Krzysztof Bielawski, Anna Bielawska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/7/2045 |
Similar Items
-
The activity of pyrazolo[4,3-e][1,2,4]triazine and pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures
by: Anna Szymanowska, et al.
Published: (2024-12-01) -
Pyrazolo[4,3-<i>e</i>]tetrazolo[1,5-<i>b</i>][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro
by: Karol Bukowski, et al.
Published: (2022-06-01) -
Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-<i>e</i>][1,2,4]triazine Derivatives
by: Zofia Bernat, et al.
Published: (2020-08-01) -
Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity
by: Mariusz Mojzych, et al.
Published: (2017-01-01) -
Chiral Pyrazolo[4,3-<i>e</i>][1,2,4]triazine Sulfonamides—Their Biological Activity, Lipophilicity, Protein Affinity, and Metabolic Transformations
by: Zofia Bernat, et al.
Published: (2021-03-01)